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Calcium signaling plays a central role in bone development and homeostasis. Store operated calcium entry 
(SOCE) is an important calcium influx pathway mediated by calcium release activated calcium (CRAC) channels 
in the plasma membrane. Stromal interaction molecule 1 (STIM1) is an endoplasmic reticulum calcium sensing 
protein important for SOCE. 
We generated a mouse model expressing the STIM1 R304W mutation, causing Stormorken syndrome in 
humans. Stim1R304W/R304W mice showed perinatal lethality, and the only three animals that survived into 
adulthood presented with reduced growth, low body weight, and thoracic kyphosis. Radiographs revealed a 
reduced number of ribs in the Stim1R304W/R304W mice. Microcomputed tomography  data  revealed  decreased 
cortical bone thickness and increased trabecular bone volume fraction in Stim1R304W/R304W mice, which had 
thinner and more compact bone compared to wild type mice. The Stim1R304W/+ mice showed an intermediate 
phenotype. Histological analyses showed that the Stim1R304W/R304W mice had abnormal bone architecture, with 
markedly increased number of trabeculae and reduced bone marrow cavity. Homozygous mice showed STIM1 
positive osteocytes and osteoblasts. These findings highlight the critical role of the gain-of-function (GoF) STIM1 
R304W protein in skeletal development and homeostasis in mice. Furthermore, the novel feature of bilateral 
subgingival hair growth on the lower incisors in the Stim1R304W/R304W mice and 25 % of the heterozygous mice 
indicate that the GoF STIM1 R304W protein also induces an abnormal epithelial cell fate. 
 
 
 
 
1. Introduction 
 
Calcium signaling plays an important role in bone development and 
homeostasis [1]. One important Ca2+  entry pathway in non-excitable 
 
cells is the store-operated Ca2+ entry (SOCE) [2,3]. SOCE is mediated 
by stromal interaction molecule 1 (STIM1), a single-pass transmem- 
brane protein, which resides in the endoplasmic reticulum (ER) mem- 
brane and senses ER Ca2+  levels [4]. When ER Ca2+  stores are low, 
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STIM1 oligomerizes and translocates to ER-plasma membrane (ER-PM) 
junctions [5,6]. At these junctions, STIM1 interacts with ORAI1, a tetra- 
spanning PM protein. ORAI1 forms the ion-conducting pore of the Ca2+ 
release-activated Ca2+ channel (CRAC) and enables Ca2+ influx across 
PM [2,3,7–9]. The study of patients and mouse models with mutations 
in ORAI1 or STIM1 genes contribute to the understanding of the func- 
tion of these proteins through phenotypes related to dysregulated SOCE 
[8,10–15]. 
Mutations in the ORAI1 or STIM1 genes cause diseases in human 
[9–11,13–15]. Bi-allelic loss-of-function (LoF) mutations in STIM1 or 
ORAI1 result in absence of SOCE and patients present with Im- 
munodeficiency 10 (IMD10, OMIM #612783) or Immunodeficiency 9 
(IMD9, OMIM #612782) [12,15], respectively. The clinical presenta- 
tion includes immunodeficiency, autoimmunity, ectodermal dysplasia, 
muscular hypotonia, and severe dental enamel defects, which high- 
lights the role of CRAC in tooth development [8,9,12,15–17]. Hetero- 
zygous gain-of-function (GoF) mutations in STIM1 and ORAI1 in hu- 
mans cause constitutive SOCE resulting in a spectrum of diseases 
ranging from isolated tubular aggregate myopathy (TAM) (TAM1, 
OMIM #160565, TAM2, OMIM #615883) to Stormorken syndrome 
(STRMK, OMIM #185070) [15–18]. Stormorken syndrome, caused by 
the STIM1 c.910C > T; p.R304W mutation, is a rare multi-organ dis- 
ease, presenting with tubular aggregate myopathy, fatigue, anemia, 
thrombocytopathy, thrombocytopenia, miosis, asplenia, ichthyosis, and 
headache [10,13,14,18–20]. Interestingly, the effect of GoF STIM1 
mutations in the skeletal or dental tissues has not been explored in 
patients with TAM or Stormorken syndrome [13,14,18,20–23]. 
Stim1-/-  and Orai1-/- mouse models have provided insight into the 
effects of absent SOCE and the resulting cellular Ca2+ dysregulation 
[24–28]. These mice present with neonatal lethality, where the sur- 
viving mice from both knock-out models displayed significantly re- 
duced growth [24,26–28]. In addition, the Orai1-/- mice presented with 
a severe osteoporotic bone phenotype, characterized by a decreased 
bone volume versus tissue volume and decreased trabecular number 
and increased trabecular spacing [26]. 
On the other hand, mouse models expressing STIM1 GoF mutations 
causing constitutive SOCE also manifested pathological features 
[29–31]. Heterozygous Stim1Sax mice expressing the STIM1 EF-hand 
mutation D84G [30], which causes TAM1 in humans [10], developed 
spleen abnormalities including increased spleen size and abnormal red 
and white pulp architecture. The Stim1Sax mice also show bone marrow 
fibrosis and increased collagen deposition which affected the femoral 
bone cavity in heterozygous state [30]. Two mouse models expressing 
STIM1 R304W have been reported [29,31]. Both models are described 
with reduced body size, hematological and muscular defects, and 
homozygous lethality. The Stim1R304W model described by Silva-Rojas 
et al., also displayed spleen enlargement, reduced bone marrow cavity, 
abnormal cortical and trabecular architecture and diminished bone 
strength [31]. 
In this paper, we extend the phenotyping of our mouse line ex- 
pressing the STIM1 R304W mutation, named Stim1R304W [29], to fur- 
ther elucidate the abnormalities in the skeletal system due to con- 
stitutive SOCE. We describe macroscopic skeletal anomalies and severe 
changes in the bone architecture in the Stim1R304W mice, as well as a 
novel feature of ectopic subgingival hair growth on the labial side of the 
lower incisors. 
 
2. Methods 
 
2.1. Maintenance of mice 
 
All animals were housed at standard conditions (12:12-hr light/ 
dark, 21 ± 2 °C temperature and 55 ± 5 % relative humidity) with ad 
libitum access to water and standard chow. All animal experimental 
protocols for generation, breeding and use of transgenic animals in 
Norway were registered and approved by the Norwegian Food Safety 
Authority (Mattilsynet, Experimental animal welfare supervision and 
application system ID 7216 and 6991) and followed the ethical guide- 
lines given in Directive 2010/63/EU of the European Parliament on the 
protection of animals used for scientific purposes. 
The  Stim1R304W   mouse  model  carrying  the  Stim1  (NC_000073.6) 
chr7:102421471A > T (GRCm38.p4) mutation, resulting in a R304W 
amino acid substitution in STIM1 was established by Gamage et al. 
[29]. The mouse line was generated on a C57bl6xCBA F1 background 
using Zinc Finger technology [29]. All animals in the study were eu- 
thanized at 5–6 months of age and a full necropsy was performed. 
Tissues were stored in 10 % formalin or snap frozen until further ana- 
lysis. 
 
2.2. Spleen measurement 
 
Total body weight was measured in live animals before euthanasia. 
Upon euthanasia, the  spleen of each animal was dissected, photo- 
graphed, weighed and length measured. The size of spleen is presented 
as a ratio of spleen and total body mass at euthanasia. 
 
2.3. Whole mouse radiographs 
 
Whole animal radiography of formalin fixed mice was  performed 
using Philips X-ray generator and tube (Philips Norge AS, Health 
Systems,Oslo, Norway) and Sound Eklin DR developer (Medivet 
Scandinavian AB, Ängelholm, Sweden). 
 
2.4. Microcomputed tomography (μCT) analysis of the tibia 
 
Microcomputed tomography (μCT) scanning was performed to 
measure morphological indices of metaphyseal regions of tibias. 
Formalin fixed bone samples wrapped in plastic foil were rotated 
around their long axes with a rotation step of 0.4° and images were 
acquired using Bruker Skyscan 1172 (Bruker, Kontich, Belgium) with 
the  following  parameters:  pixel  size  =5 μm;  peak  tube potential 
=100 kV; X-ray intensity =100 μA; 0.5-mm aluminum filter. Raw 
images were reconstructed by the NRecon Reconstruction Software 
(Microphotonics, Inc. Allentown, PA) to 3-dimensional cross-sectional 
image data sets, using a 3-dimensional cone beam algorithm. For the 
reconstruction, beam hardening was set to 0 %, smoothing to 1, and 
ring artefact reduction to 10. Structural indices were calculated on re- 
constructed images using the CT-Analyser (CTAn) software package 
(Blue Scientific Limited, Cambridge, UK). Cortical and trabecular bone 
were separated using a custom processing algorithm in CTAn, based on 
the different thicknesses of the structures. Cortical bone was analyzed 
by a region  of 180  slices, starting 9 mm distal to the metaphysis. 
Cortical parameters included mean total cross sectional area, cortical 
bone volume and cortical bone area. Trabecular bone was analyzed in 
the proximal metaphysis region, starting just distal to the metaphysis 
and continued distally for 240 slices. Trabecular parameters included 
trabecular separation, trabecular bone volume fraction and trabecular 
number. 
 
2.5. Histology 
 
Formalin fixed tibiae from Stim1+/+ and Stim1R304W/R304W mice, 
were decalcified in a decalcification solution (34 g Sodium formate 
(HCOONa), 151 ml concentrated formic acid, 1 L H2O) for 24 h and 
paraffin embedded. The tissue blocks were then sectioned at 4 μm 
thickness and stained with hematoxylin and eosin (HE) using standard 
protocols. 
 
2.6. Immunohistochemistry 
 
Adjacent sections obtained from tissue block sectioning were 
stained for STIM1 using the avidin-biotin method with the Vectastain 
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Fig. 1. Thoracic kyphosis and 12 pairs of ribs in the Stim1R304W/ R304W mice. 
(A–B) Lateral view of a representative Stim1R304W/R304W  mouse showing thoracic kyphosis (arrowhead) (A), confirmed by whole body X-ray (B). 
(C) Representative image of a chest X-ray from Stim1R304W/R304W  mouse showing 12 pairs of ribs. 
 
Elite ABC System (PK-6100, Vector Laboratories, Burlingame, CA, 
USA). Sections were de-paraffinized and antigen retrieval performed at 
92 °C for 5 min, in citrate buffer (0.01 M, pH 6.0) followed by a 5 min 
incubation in the heated solution. Sections were rinsed in distilled H2O 
and the process was repeated, followed by 15 min incubation in the 
heated solution and 15 min incubation in 3 % H2O2 in methanol/dis- 
tilled H2O, and stored overnight at 4 °C in phosphate buffered saline 
(PBS). The sections were blocked for 30 min in 1:100 normal goat 
serum in PBS and stained with 1:400 anti-human STIM1 (LS-C209377, 
LifeSpan BioSciences, Inc., Seattle WA, USA) for 1 h at room tempera- 
ture on a rotating table followed by a 30 min incubation with 1:50 
biotinylated goat anti-rabbit antibody (Vectastain kit). Samples were 
washed and treated with avidin (1:50 in PBS) and biotinylated horse- 
radish peroxidase (1:50 in PBS), for 30 min at room temperature fol- 
lowed by rinse with PBS with 0.05 % Tween 20. The STIM1 signal was 
developed for 8 min with ImmPACT AEC (SK-4205, Vector 
Laboratories). The sections were subsequently contrast stained with 
hematoxylin and mounted in xylene. 
 
2.7. Macroscopy and scanning electron microscopy (SEM) of mouse dental 
structures 
 
All animals aged 5 weeks to 6 months were examined macro- 
scopically for presence of ectopic subgingival hair growth below the 
lower central incisors. Jaws were dissected at euthanasia at 5–6 months 
age, stored in formalin and or PBS and shipped at room temperature to 
NYU College of Dentistry for Backscattered Scanning Electron 
Microscopy (BSE-SEM) analysis as reported previously [32]. Briefly, 
mandibles of WT and Stim1R304W mice were extracted and cleared of 
soft tissues, dehydrated, embedded in PMMA resin before sectioning 
about 2 mm from the incisor tip. After polishing, samples were imaged 
in parallel in the BSE-SEM without conductive coating setting contrast 
and brightness to the WT sample. 
 
2.8. Re-analysis of X-rays and computed tomography (CT) scans from 
patients with Stormorken syndrome 
 
Available radiographs from patients F1 III-1, F2 II-3, F3 II-1 and F4 
III-1 described by Misceo et al., [13] were collected and assessed ret- 
rospectively. Images collected include: computed tomography (CT) of 
the neck, chest and abdomen of F1 III-1; CT of the head and radiographs 
of chest, hands and lower extremities in F2 II-3; radiographs of cervical 
spine and lower extremities in F3 II-1; and finally, CT of the head, chest 
and abdomen and radiographs of the spine of F4 III-1 (numbers as 
previously reported). Chest X-rays from patient F1 III-2 described by 
Nesin et al., [14] and the patient described by Borsani et al. [33], were 
also assessed. 
 
2.9. Statistics 
 
Statistical analyses of μCT parameters were performed using  the 
SPSS Statistics software (IBM Corp. Released 2017. IBM SPSS Statistics 
for Windows, Version 25.0. Armonk, NY: IBM Corp.). Exact significance 
was tested based on Mann-Whitney U test (2-tailed) to compare the 
differences between groups. A p-value < 0.05 was defined as statisti- 
cally significant. Student’s t-test (unpaired) was used to evaluate sig- 
nificant differences in the spleen to body mass ratios. 
 
3. Results 
 
3.1. Stim1R304W/ R304W mice showed thoracic kyphosis and reduced 
number of ribs 
 
A knock-in mouse line expressing the STIM1 R304W mutation was 
established [29]. This resulted in perinatal lethality in homozygous 
state. Only three homozygous mice survived into adulthood following 
25 heterozygous crosses, which in total resulted in 130 offspring. The 
surviving mice presented with reduced growth and body size compared 
to age and sex matched wild type littermates [29]. 
The three homozygous mice were euthanized at 5–6 months of age 
and stored in formalin before the examination of the skeletons. 
Macroscopic examination of the mice revealed thoracic kyphosis, which 
was further documented by whole body X-ray radiographs (Fig. 1A–B). 
The radiographs also revealed the presence of 12 pairs of ribs in all 
three Stim1R304W/R304W mice (Fig. 1C), which is in contrast to the 13 
pairs of ribs in wild type mice. No other abnormal features were ob- 
served on X-ray. Thoracic kyphosis was not detected by macroscopic 
examination of 91 heterozygous Stim1R304W/+ mice. Further micro- 
computed tomography (μCT) scans and data analysis did not detect 
differences in the femur to tibia length ratios in the homozygous mice 
compared to wild type (data not shown). Therefore, the X-ray and μCT 
results indicated that the skeleton of the Stim1R304W/R304W mice were 
smaller, but proportionate in comparison to the wild type mice. 
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3.2. Patients with the STIM1 R304W mutation did not present with clear 
skeletal anomalies 
 
Motivated by the skeletal anomalies in the Stim1R304W mouse line, 
we did a retrospective analysis on chest X-ray and CT scans in six pa- 
tients with Stormorken syndrome [13,14,33]. We did not detect skeletal 
abnormalities in ribs and spine in patient F1 III-1 and F3 II-1 reported 
by Misceo et al., [13], in patient F1 III-2 described by Nesin et al., [14], 
and in the patient described by Borsani et al., [33]. Patient F2 II-3 in 
Misceo et al. [13], also had a normal spine and normal number of pairs 
of ribs, but rib number 5 on the right side was bifid anteriorly, and 
presented with periarticular soft tissue calcifications. Patient F4 III-1 in 
Misceo et al.,  [13] had normal vertebrae  and number of  ribs, but 
showed a slight thoracic scoliosis of about 25°. Bone density was con- 
sidered normal in all patients evaluated by CT and or X-ray radio- 
graphs, including normal thickness of the cortical bone. However, it 
should be noted that these patients maintain a wild type STIM1 allele, 
in contrast to the mice that are homozygous for the Stormorken mu- 
tation, which thus are expected to have a more severe phenotype. The 
subtle skeletal features in these patients call for examination of more 
patients with Stormorken syndrome or other GoF STIM1 mutations to 
assess for the presence of skeletal anomalies. 
 
 
3.3. Abnormal bone architecture in the Stim1R304W mouse line 
 
Macroscopic examinations of cross sections of the femurs revealed 
normal bone marrow cavity in the wild type mice, but narrow, almost 
absent bone marrow cavity in the three Stim1R304W/R304W  mice. 
In the Stim1R304W/R304W mice μCT analyses of the tibiae docu- 
mented pathogenic changes in trabecular and cortical bone architecture 
compared to age and sex matched wild type mice (Fig. 2A–I). The 
homozygous mice showed significantly decreased trabecular separation 
(p < 0.05), increased trabecular bone volume fraction (p < 0.05) and 
trabecular number (p < 0.05) (Fig. 2D–F) compared to wild type mice. 
They also showed a decrease in mean total cross-sectional cortical bone 
area (p < 0.05), cortical bone volume (p < 0.05) and cortical bone 
surface area (p < 0.05) (Fig. 2G–I). The heterozygous mice showed an 
intermediate phenotype between the wild type and the homozygous 
mice (Fig. 2D–F). Thus, the Stim1R304W mouse line presented with pa- 
thological features in the skeletal system, which includes decreased 
cortical bone volume and an increased trabecular bone volume fraction, 
with thinner and more compact trabeculae (Fig. 2A–I). 
Histological examination of HE stained sections of the proximal 
segment of the tibial diaphysis of wild type mice showed normal ossi- 
fication with slender bone trabeculae and an abundant bone marrow. In 
contrast, the Stim1R304W/R304W mice presented with reduced bone 
marrow cavity, resulting in a more compact morphology (Fig. 3A–D). 
 
 
3.4. STIM1 R304W was expressed in megakaryocytes, osteoblasts and 
osteocytes 
 
The expression of the STIM1 protein in bone was assessed by IHC on 
bone sections from tibiae of homozygous and wild type mice. The data 
showed that the osteoblasts lining the bone trabeculae and the osteo- 
cytes embedded in the bone matrix were strongly positive for STIM1 in 
both wild type and Stim1R304W/R304W  mice (Fig. 3E and F). 
We previously documented lack of STIM1 protein in platelets from 
the Stim1R304W/R304W→WT chimeras and in embryonic liver mega- 
karyocytes from the Stim1R304W/R304W mice [29]. In the only three 
Stim1R304W/R304W mice surviving to adulthood, however, bone marrow 
megakaryocytes stained positive for STIM1 by IHC (Fig. 4). Thus, the 
mutant protein was detected in the hematopoietic lineage in all the 
three Stim1R304W/R304W mice surviving to adulthood. 
3.5. Stim1R304W/R304W  mice presented with splenomegaly 
 
Stim1R304W/R304W mice presented splenomegaly and showed a mean 
spleen to body mass ratio of 0.0125 (n = 3) while WT was 0.00275 
(n = 18) (p < 0.005) (Fig. 5). Splenomegaly is observed in mice with 
impaired bone marrow activity [34], and was also detected in the 
Stim1R304W mice described by Silva-Rojas et al. [31]. 
 
3.6. The Stim1R304W mouse line presented with bilateral subgingival hair 
growth on the lower incisors 
 
All three homozygous Stim1R304W/R304W mice presented with hair 
originating from the labial side of the lower incisors, which became 
evident within the first two months of life (Fig. 6A). Similar ectopic 
subgingival hair growth on the lower incisors was also detected in 18/ 
70 (26 %) of the heterozygous Stim1R304W/+  mice examined. 
The color and structure of the incisors of the Stim1R304W/R304W mice 
was comparable to the wild type littermates. The incisors did not have a 
‘chalky’ appearance, which could have indicated abnormal miner- 
alization. Cross sections of incisor enamel from one wild type and one 
Stim1R304W/R304W mouse were  imaged  in BSE-SEM to  assess broad 
differences in mineralization of the enamel. Wild type and Stim1R304W/ 
R304W  mice  did  not  show  significant  mineralization   differences 
(Fig. 6B–C). Together, these data point to a defect in epithelial cell fate 
in Stim1R304W mouse line, not previously described in mice with Stim1 
or Orai1 mutations. 
 
4. Discussion 
 
Store-operated calcium channels (SOCE) serve as a main Ca2+ 
regulating mechanism in both bone and dental tissue growth and de- 
velopment in man and mouse. This is evident in patients with Ca2+ 
release-activated Ca2+  (CRAC) channelopathies, who present with de- 
fects in dental enamel mineralization [8]. A dental phenotype with 
chalky enamel is also observed in Stim1-deficient mice [35,36]. In the 
bone, ORAI1 regulates osteoblast and osteoclast formation and differ- 
entiation [37]. The role of STIM1 in these processes is less understood 
[38]. However, based on the importance of SOCE, it can be hypothe- 
sized that STIM1 also plays a critical role in these processes and any 
disruption in STIM1 function may result in imbalances of bone home- 
ostasis and in dental enamel formation. The Stim1R304W mouse model 
demonstrates that constitutive SOCE due to the GoF Stim1 mutation 
results in skeletal defects and abnormal epithelial cell fate, thereby 
making Stim1R304W mice a tool for exploring the effects of constitutive 
SOCE induced Ca2+ dysregulation in these tissues. 
STIM1 GoF mutations are pathogenic in mice, but the cellular and 
phenotypic effects seem to be different for each mutation [29–31]. 
Embryonic lethality at < 14.5 dpc caused by severe bleeding is de- 
scribed in mice expressing the EF-hand GoF mutation STIM1 D84G 
[30], while homozygous Stim1 R304W mice died perinatally with no 
signs of bleeding [29]. STIM1 is important in muscle at early devel- 
opmental stages [39,40], and both the heterozygous Stim1 R304W/+ 
mice and the surviving homozygotes showed severe skeletal muscle 
degeneration [29], indicating that the cause of lethality may be un- 
derstood by further studies of the muscle pathology in our Stim1R304W 
mice. 
Our Stim1R304W mice showed macroscopic skeletal anomalies: pro- 
portionally small skeleton, reduced number of ribs and kyphosis in 
Stim1R304W/R304W mice. We further documented severe microscopic 
anomalies in the bone architecture of these mice, with increased tra- 
becular to cortical bone fraction, and almost absent bone marrow 
cavity. This is in line with the observations in the mouse model de- 
scribed by Silva-Rojas et al. [31], expressing the same mutation, which 
presented with decreased cellular density, reduced bone marrow cavity 
and abnormal mechanical bone properties. In contrast, re-analysis of X- 
ray and CT scans of six patients with Stormorken syndrome expressing 
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Fig. 2. μCT analyses of the tibia showed in- 
creased trabecular to cortical bone fraction in 
Stim1R304W   mice. 
(A–C) 3D projections of μCT scanning of tibia 
from Stim1R304W/R304W and wild type mice as 
indicated. Homozygous mice presented de- 
creased cortical bone volume (B) and increased 
trabecular bone volume fraction with thinner 
and more compact trabeculae (C) compared to 
the wild types. 
(D–I) Homozygous mice (n = 3) presented 
with significantly decreased trabecular se- 
paration (D), increased trabecular bone vo- 
lume fraction (E) and trabecular number (F) 
compared to wild type mice (n = 6). 
Significantly decreased mean total cross sec- 
tional area (G), cortical bone volume (H) and 
cortical bone area (I) were also seen in 
Stim1R304W/R304W mice (n = 3) in comparison 
to age matched wild type mice (n = 6). 
Heterozygous Stim1R304W mice (n = 6) showed 
an intermediate phenotype between wild type 
and homozygous littermates in all aspects 
above (D–F). 
In all panels, p-values for significance are in- 
dicated as *=p < 0.05. 
B.Ar: bone area; B.S: bone volume fraction; BV: 
bone volume; BV/TV: bone volume/trabecular 
volume; Het: heterozygous; Hom: homozygous; 
Tb. N: trabecular number; Tb. Sp: trabecular 
separation; WT: wild type. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
the STIM1 R304W mutation detected only minor and varied anomalies, 
which may also be observed in otherwise healthy individuals. Skeletal 
examination of additional patients with Stormorken syndrome is 
needed to assess if STIM1 GoF mutations cause skeletal anomalies in 
humans. 
We previously showed that STIM1 expression was reduced or un- 
detectable in megakaryocytes and platelets of our heterozygous and 
homozygous Stim1R304W mice at embryonic stages and in fetal liver 
chimeras [29]. However, the three homozygous Stim1R304W mice sur- 
viving to adulthood showed STIM1 expression in bone marrow mega- 
karyocytes (Fig. 4), documenting expression of the mutant protein in 
the hematopoietic lineage. Osteoclasts also originate from hemato- 
poietic stem cells, which differentiate to form monocyte precursors that 
subsequently fuse into mature multinucleated osteoclasts, which med- 
iate bone resorption by decalcifying and degrading the bone matrix 
[41]. ORAI1 and STIM1 are required for the mononuclear osteoclast 
fusion, a vital step of the late osteoclast differentiation [42], and Orai1 
KO  mice  show  reduced  trabecular  thickness  and  reduced  cortical 
ossification [26]. The Stim1R304W mice, however, showed increased 
trabecular bone volume and number. Because the hematopoietic cells of 
adult homozygous Stim1R304W mice showed STIM1 expression and 
because the bone phenotype of homozygous and heterozygous 
Stim1R304W mice differed from the phenotype of mice lacking ORAI1, it 
is reasonable to postulate that the mutant STIM1 is also expressed in the 
osteoclasts in the adult homozygous Stim1R304W  mice. 
Osteoblasts, which secrete matrix proteins necessary for bone mi- 
neralization, originate from mesenchymal stem cells in the bone 
marrow [43,44]. STIM1 is highly expressed in pre-osteoblasts [44], 
where Ca2+ signaling is essential for their differentiation into mature 
osteoblasts [45]. We documented expression of the mutant STIM1 
R304W protein in the osteoblasts in the homozygous Stim1R304W mice. 
However, more studies are required into the development and function 
of both osteoblasts and osteoclasts associated with CRAC  channel 
function to understand the exact mechanism and cell type affected in 
our Stim1R304W  mice leading to the pathogenic phenotype. 
Mice naturally have an insufficient total bone marrow volume, and 
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Fig. 3. HE and IHC staining of sections of 
proximal tibia from Stim1R304W/R304W and wild 
type mice. 
(A–B) Ossification of the proximal tibia of age 
matched wild type (WT) and Stim1R304W/R304W 
(Hom) mice. 
Wild type mice showed normal ossification 
with slender bone trabeculae and abundant 
bone marrow (A), while Stim1R304W/R304W 
consistently show increased bone mass with 
broad bone trabeculae and relatively sparse 
bone marrow by HE staining (B) (magnifica- 
tion   25×). 
(C–D) HE stained sections of the proximal tibia 
from a wild type and Stim1R304W/R304W, re- 
spectively (magnification 400×). 
(E–F) IHC of sections (STIM1) from wild type 
(E) and Stim1R304W/R304W mice (F) showed 
strongly STIM1 positive osteoblasts (arrows) 
and embedded osteocytes (arrowheads) (mag- 
nification   400×). 
bm: bone marrow; t: trabeculae. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. STIM1 staining in megakaryocytes from bone marrow of Stim1R304W/R304W  mice. 
IHC  of  bone  marrow  showed  STIM1  expression  in  megakaryocytes  in  adult  wild  type,  Stim1R304W/+   and  Stim1R304W/R304W   mice  (n = 2)  (arrowheads) 
(Magnification: 400x). 
Het: heterozygous; Hom: homozygous; WT: wild type. 
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Ca2+ content [35,36]. However the effect of increased SOCE activity 
due to overactive STIM1 in dental enamel in mice is not described. 
Expression of the GoF STIM1 R304W mutation in our StimR304W mice 
did not seem to cause obvious mineralization differences when com- 
paring to wild type animals by BSE-SEM of incisor enamel. This is in 
line with the previously reported observation of normal enamel mi- 
neralization in mice with increased SOCE due to knock-down of Orai2 
[25]. Together these observations indicate that lack of SOCE has more 
substantial pathogenic impact on the enamel mineralization than con- 
stitutive SOCE in mice. 
The ectopic subgingival hair structures in the Stim1R304W  mice do 
not seem to replace enamel growth, but are rather generated in addition 
to the normal enamel. Rodent incisors have a stem cell compartment at 
the base (the cervical loop) enabling continuous growth of the tooth, as 
cells differentiate into different cell types including ameloblasts [46]. 
Tooth morphogenesis is similar to that of hair and other ectodermal 
tissues [46], but hair growth in gingiva is uncommon. However, a si- 
milar ectopic hair growth as described in our Stim1R304W mice was 
reported in the epithelium specific mediator complex subunit 1 (Med1) 
knock-out mouse model [47]. Yoshizaki et al. [47] suggested that in 
these mice the lack of Med1 caused reduced Notch signaling; a pathway 
which regulates cell fate in different tissues including the dental epi- 
thelial cells [48]. With reduced Notch signaling, the dental epithelia 
converted into epidermal epithelia due to failure in committing to a 
dental lineage. This in turn caused defects in the development of en- 
amel, while promoting hair growth in Med1 KO mice [47,48]. Fur- 
thermore, epidermal fate is induced by Ca2+ [47]. However, elevated 
Ca2+ is also known to downregulate Notch signaling causing defects in 
cell lineage commitment [49]. Thus, dysregulation of the Ca2+ driven 
epithelial cell fate may be the cause of the ectopic hair growth in the 
Stim1R304W mice. The ectopic subgingival hair development suggest a 
potential suppression of the Notch pathway in Stim1R304W/R304W mice. 
It is tempting to hypothesize that a similar suppression of the Notch 
pathway in mesenchymal progenitor cells, osteoblasts, osteocytes and/ 
or osteoclasts, which express STIM1 and are all known to be affected by 
the Notch signaling [50], could explain part of the skeletal phenotype of 
these mice. 
 
5. Conclusion 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Stim1R304W 
 
 
 
 
 
 
 
 
 
 
 
homozygous mice presented with splenomegaly. 
The Stim1R304W mouse line presented a skeletal phenotype char- 
acterized by significant pathogenicity in trabecular and cortical bone, 
kyphosis, reduced number of ribs, and reduced bone marrow cavity. In 
addition, the mice showed splenomegaly and ectopic growth of sub- 
gingival hair possibly caused by a defect in epithelial cell fate. Our data 
further confirm the previous reports that elevated SOCE does not seem 
to affect enamel mineralization [25], but cause severe defects in bone 
architecture in mice [30,31]. This further highlights the importance of 
the ER-protein STIM1 in skeletal system development and homeostasis. 
(A) A  significantly  increased  spleen  to  body  mass  ratio  was  observed  in 
R304W Further studies of the osteoclasts, osteoblasts, ameloblasts and epithe- 
homozygous  Stim1 
(n = 18) (*=p < 0.005). 
mice (n = 3) compared to wild type littermates lial stem cells expressing the mutant STIM1 R304W protein may reveal 
the  dysregulated  molecular  pathways  that  cause  the  observed  ab- 
(B) Representative images of dissected spleen from age matched wild type and 
Stim1R304W/R304W  mouse as indicated. Hom: homozygous; WT: wild type. 
 
the murine spleen is an essential extension of the hematopoietic organ 
[34]. Furthermore, impaired bone marrow activity causes enlargement 
of the spleen in mice due to a higher demand of spleen functionality 
[34]. In line with this, the homozygous Stim1R304W mice showed 
splenomegaly and a reduced bone marrow cavity with less abundant 
bone marrow. Similar observations of splenomegaly in parallel with 
bone marrow reduction were reported in the Stim1Sax mouse model 
[30] and in the Stim1R304W mouse model reported by Silva-Rojas et al. 
[31]. 
Impaired SOCE in enamel cells in mice, due to lack of Stim1 caused 
hypo-mineralized, thin and mechanically weak enamel, with reduced 
normalities in the Stim1R304W  mouse line. 
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Fig. 6. Ectopic subgingival hair growth in the Stim1R304W  mouse line. 
(A) Representative image from a Stim1R304W/R304W mouse shows bilateral ectopic hair growth from the labial side of the lower incisors appearing to originate from 
the gingiva. Macroscopic enamel morphology appeared normal, without chalky appearance. 
(B–C) BSE-SEM of cross section of incisors did not reveal differences in signals (brightness) between the wild type (B) and the Stim1R304W/R304W mouse (C). 
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